Invasive procedures to evaluate the fetus

Clinical Obstetrics and Gynecology

Volumn 45, Issue 4, 2002, Pages 1039-1053

  Dugoff, Lorraine ^a   Hobbins, John C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; RHESUS D ANTIBODY; ZIDOVUDINE;

AMNIOCENTESIS; AMNION FLUID; CHEMOPROPHYLAXIS; CHORION VILLUS SAMPLING; CHROMOSOME DISORDER; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EVALUATION; FETUS; FETUS DEATH; FETUS RISK; FETUS WASTAGE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIMB DEFECT; META ANALYSIS; NEEDLE; NEWBORN DEATH; NEWBORN HEMOLYTIC DISEASE; PERCUTANEOUS UMBILICAL BLOOD SAMPLING; PES EQUINOVARUS; PLACENTA; PNEUMONIA; POSITION; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PUNCTURE; RESPIRATORY DISTRESS SYNDROME; REVIEW; RHESUS ISOIMMUNIZATION; SAFETY; SPONTANEOUS ABORTION; TECHNIQUE; TRANSCERVICAL CHORION VILLUS SAMPLING; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TROPHOBLAST; TWIN PREGNANCY; ULTRASOUND; UMBILICAL CORD; UMBILICAL CORD BLOOD; UMBILICAL VEIN; VERTICAL TRANSMISSION;

AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; CORDOCENTESIS; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY, MULTIPLE; RANDOMIZED CONTROLLED TRIALS; RH ISOIMMUNIZATION; RISK FACTORS; TIME FACTORS;

EID: 0036891956     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200212000-00010     Document Type: Review

References (95)

1. Serr DM, Sachs L, Danon M. Diagnosis of sex before birth using cells from the amniotic fluid. Bull Res Council Isr. 1955;58:137.
2. Fuchs F, Riis R. Antenatal sex determination. Nature. 1956;177:330.
3. Steele MW, Breg WR. Chromosome analysis of human amniotic cells. Hum Genet. 1970;1:383.
4. Jacobson CB, Barter RH. Intrauterine diagnosis and management of genetic defects. Am J Obstet Gynecol. 1967;99:795-807.
5. Valenti C, Schutta EJ, Kehaty T. Prenatal diagnosis of Down's syndrome. Lancet. 1968;2(7561):220.
6. Nicolaides KH, Sebire NJ, Snijders RJM. The 11-14 Week Scan: The Diagnosis of Fetal Abnormalities. New York: Parthenon Publishing Group, 1999.
7. Jeanty P, Rodesch F, Romero R, et al. How to improve your amniocentesis technique. Am J Obstet Gynecol. 1983;146:593-596.
8. Nicolini U, Monni G. Intestinal obstruction in babies exposed in utero to methylene blue. Lancet. 1990;336(8725):1258-1259.
9. van de Pol JH, Wolf H, Boer K, et al. Jejunal atresia related to the use of methylene blue in genetic amniocentesis in twins. Br J Obstet Gynaecol. 1992;99:141-143.
10. Kidd SA, Lancaster PAL, Anderson JC, et al. Fetal death after exposure to methylene blue dye during mid-trimester amniocentesis in twin pregnancies. Prenat Diagn. 1996;16:39-47.
11. Jeanty P, Shah D, Roussis P. Single-needle insertion in twin amniocentesis. J Ultrasound Med. 1990;9:511.
12. Buscaglia M, Ghisoni L, Belloti M, et al. Genetic amniocentesis in biamniotic twin pregnancies by a single transabdominal insertion of the needle. Prenat Diagn. 1995;15:17-19.
13. Bahado-Singh R, Schmitt R, Hobbins JC. New technique for genetic amniocentesis in twins. Obstet Gynecol. 1992;79:304-307.
14. Yukobowich E, Anteby EY, Cohen SM, et al. Risk of fetal loss in twin pregnancies undergoing second trimester amniocentesis. Obstet Gynecol. 2001;98:231-234.
15. The NICHD National Registry for Amniocentesis Study Group. Midtrimester amniocentesis for prenatal diagnosis: Safety and accuracy. JAMA. 1976;236:1471-1476.
16. Simpson NE, Dallaire L, Miller JR, et al. Prenatal diagnosis of genetic disease in Canada: Report of a collaborative study. Can Med Assoc J. 1976;115:739-748.
17. Working Party on Amniocentesis. An assessment of the hazards of amniocentesis. Br J Obstet Gynaecol. 1978;85(Suppl 2):1-41.
18. Tabor A, Philip J, Madsen M, et al. Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1986;1 (8493):1287-1293.
19. Papantoniou NE, Daskalakis GJ, Tziotis JG, et al. Risk factors predisposing to fetal loss after a second-trimester amniocentesis. Br J Obstet Gynecol. 2001;108:1053-1056.
20. Bombard AT, Powers JF, Carter S, et al. Procedure-related fetal losses in transplacental versus non-transplacental genetic amniocentesis. Am J Obstet Gynecol. 1995;172:868-872.
21. Giorlandino C, Mobili L, Bilancioni E, et al. Transplacental amniocentesis: Is it really a higher-risk procedure? Prenat Diagn. 1994;14:803-806.
22. Lynch L: Second-trimester prenatal diagnosis. In Reece EA, Hobbins JC, eds. Medicine of the Fetus and Mother, 2d Ed. Philadelphia: Lippincott-Raven, 1999:679-687.
23. Borgida AF, Mills AA, Feldman DM, et al. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol. 2000;183:937-939.
24. Murken JA, Stengel-Rutkowski S, Schwinder E. In prenatal diagnosis. Proceedings of the Third European Conference on Prenatal Diagnosis of Genetic Disorders. Stuttgart: Ferdinand Enke, 1979:132.
25. D'Alton ME. Prenatal diagnostic procedures. Semin Perinatol. 1994;18:140-162.
26. Crandall BF, Howard J, Lebher TB, et al. Follow-up of 2000 second trimester amniocentesis. Obstet Gynecol. 1980;56:625-628.
27. Bowman JM, Pollack JM. Transplacental fetal hemorrhage after amniocentesis. Obstet Gynecol. 1985;66:749-754.
28. Finegan JA, Sitarenios G, Bolan PL, et al. Children whose mothers had second-trimester amniocentesis: Follow-up at school age. Br J Obstet Gynaecol. 1996;103:214-218.
29. Baird PA, Lee IM, Sadovnick AD. Population-based study of long-term outcomes after amniocentesis. [published erratum appears in Lancet. 1994;3(8936):1582] Lancet. 1994;344(8930):1134-1136.
30. Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts. Am J Obstet Gynecol. 1996;175:661-667.
31. Tess BH, Rodrigues LC, Newell ML, et al. Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in San Paolo State, Brazil. AIDS. 1998;12:513-520.
32. Bucceri AM, Somigliana E, Vignali M. Early invasive diagnostic techniques during pregnancy in HIV-infected women. Acta Obstet Gynecol Scand. 2000;80:82-83.
33. The International Perinatal HIV group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. N Engl J Med. 1999;179:590-599.
34. Reece EA. Early and midtrimester genetic amniocentesis: Safety and outcomes. Obstet Gynecol Clin North Am. 1997;24:71-81.
35. Eiben B, Goebel R, Hansen S, et al. Early amniocentesis: A cytogenetic evaluation of over 1500 cases. Prenat Diagn. 1994;14:497-501.
36. Rousseau O, Boulot P, Lefort G, et al. Amniocentesis before 15 weeks' gestation: Technical aspects and obstetric risks. Eur J Obstet Reprod Biol. 1995;58:127-130.
37. Kerber S, Held KR. Early genetic amniocentesis: 4 Years' experience. Prenat Diagn. 1993;13:21-27.
38. Assel BG, Lewis SM, Dickerman LH, et al. Single-operator comparison of early and mid-second-trimester amniocentesis. Obstet Gynecol. 1992;79:940-944.
39. Sundberg K, Jorgensen FS, Tabor A, et al. Experience with early amniocentesis. J Perinat Med. 1995;23:149-158.
40. Tharmaratnam S, Sadek S, Steele EK, et al. Transplacental early amniocentesis and pregnancy outcome. Br J Obstet Gynaecol. 1998;105:228-230.
41. Bravo RR, Shulman LP, Phillips OP, et al. Transplacental needle passage in early amniocentesis and pregnancy loss. Obstet Gynecol. 1995;86:437-440.
42. Penso CA, Sanderstrom MM, Garber MF, et al. Early amniocentesis: Report of 407 cases with neonatal follow-up. Obstet Gynecol. 1990;76:1032-1036.
43. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. The Canadian Early and Mid-Trimester Amniocentesis Trial (CEMAT) Group. Lancet. 1998;351(9098):242-247.
44. Nicolaides K, de Lourdes Brizot M, Patel F, et al. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation. Lancet. 1994;344:455-439.
45. Sundberg K, Bang J, Smidt-Jensen S, et al. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet. 1997;350(9079):697-703.
46. Mohr J. Fetal genetic diagnosis: Development for techniques for early sampling of fetal cells. Acta Pathol Microbiol Scand. 1968;73:73-77.
47. Hahnemann N, Mohr J. Genetic diagnosis in the embryo by means of biopsy from extra-embryonic membranes. Bull Eur Soc Hum Genet. 1969;2:23.
48. Antenatal fetal diagnosis in genetic disease. Bull Eur Soc Hum Genet. 1969;3:47.
49. Tietung Hospital on Ansham Iron and Steel Co. Fetal sex prediction by sex chromatin of chorionic villi cells during early pregnancy. Chin Med J. 1975;1:117-126.
50. Kazi Z, Bakharev VA, Stygar AM. Value of the ultrasonic studies in biopsy of the chorion, according to genetic indicators. Akush-Gienkol (Mosk). 1979;8:29-31.
51. Kazy Z, Stygar AM, Bakharev AVA. Chorionic biopsy under immediate realtime (ultrasonic) control. Orv Hetil. 1980;121:2765-2766.
52. Kazy Z, Demidov VN, Stygar AM, et al. Use of real-time scanning for chorionic biopsy. Akush-Ginekol (Mosk). 1981;3:53-54.
53. Kuliev A, Jackson L, Froster U, et al. Chorionic villus sampling safety. Report of World Health Organization/EURO meeting in association with the Seventh International Conference on Early Prenatal Diagnosis of Genetic Diseases, Tel Aviv, May 21, 1994. Am J Obstet Gynecol. 1996;174:807-811.
54. Brambati B, Oldrini A, Ferrazzi E, et al. Chorionic villus sampling: An analysis of the obstetric experience of 1,000 cases. Prenat Diagn. 1987;7:157-169.
55. Smidt-Jensen S, Hahnemann N. Transabdominal fine-needle biopsy from chorionic villi in the first trimester. Prenat Diagn. 1984;4:163-169.
56. Wapner RJ. Chorionic villus sampling. Obstet Gynecol Clin North Am. 1997;24:83-109.
57. Jackson LG, Zachary JM, Fowler SE, et al. Randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N Engl J Med. 1992;327:594-598.
58. Wapner RJ, Davis GH, Johnson A, et al. A prospective comparison between transcervical and transabdominal chorionic villus sampling. Abstract No. 8, Society of Perinatal Obstetricians Meeting, Houston, 1990.
59. Elias S. New genetic tests. In Queenan JT, Hobbins JC, eds. Protocols for High-Risk Pregnancies, 3d Ed. Cambridge, MA: Blackwell Science, 1996:165-176.
60. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicenter randomized clinical trial of chorion villus sampling and amniocentesis. Lancet. 1989;1 (8646):1-6.
61. Smidt-Jensen S, Permin M, Philip J et al. Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet. 1992;340:1237-1244.
62. Ammala P, Hiilesmaa VK, Liukkonen S, et al. Randomized trial comparing first-trimester transcervical chorionic villus sampling and second-trimester amniocentesis. Prenat Diagn. 1993;13:919-927.
63. MRC Working Party on the Evaluation of Chorion Villus Sampling. Medical Research Council European Trial of chorion villus sampling. Lancet. 1991;337(8756):1491-1499.
64. Rhoads GG, Jackson LF, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 1989;320:609-617.
65. Firth HV, Boyd P, Chamberlain P, et al. Severe limb abnormalities after chorionic villus sampling at 56-66 days' gestation. Lancet. 1991;337:726.
66. Burton BK, Schultz CH, Burd LI. Limb anomalies associated with chorionic villus sampling. Obstet Gynecol. 1992;79:726.
67. Schloo R, Miney P, Holzgreve W, et al. Distal limb deficiency after chorionic villus sampling? Am J Med Genet. 1992;42:404.
68. Olney RS, Khoury MJ, Alo CJ, et al. Increased risk for transverse digital deficiency after chorionic villus sampling: Results of the United States Multistate Case-Control Study, 1988-1992. Tetralogy 1995;51:20-29.
69. Monni G, Ibba RM, Lai R, et al. Limb-reduction defects and chorion villus sampling. Lancet. 1991;337:1091.
70. Mahoney MJ for the U.S. NICHD Collaborative CVS Study Group. Limb abnormalities and chorionic villus sampling. Lancet. 1991;337:1422.
71. Jackson LG, Wapner RJ, Brambati B. Limb abnormalities and chorionic villus sampling. Lancet. 1991;337:1423.
72. Mastroiacovo P, Tozz AE, Agosti S, et al. Transverse limb reduction defects after chorion villus sampling: A retrospective cohort study. Prenat Diagn. 1993;13:1051.
73. Jahoda MGJ, Brandenberg H, Cohen-Overbeek, et al. Terminal transverse limb defects and early chorionic villus sampling: Evaluation of 4,300 cases with completed follow-up. Am J Med Genet. 1993;45:483.
74. Blakemore K, Filkins K, Luthy DA, et al. Cook obstetrics and gynecology catheter multicenter chorionic villus sampling trial: Comparison of birth defects with expected rates. Am J Obstet Gynecol. 1993;169:1022.
75. Mastroiacovo P, Botto LD. CVS and transverse limb deficiencies: Maternal age is not a confounder. Am J Med Genet. 1994;53:182.
76. Hsieh FJ, Shyu MK, Sheu BC, et al. Limb defects after chorionic villus sampling. Obstet Gynecol. 1995;85:84-88.
77. Firth HV, Boyd PA, Chamberlain PF, et al. Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet. 1994;343:1069-1071.
78. Hunter AG, Muggah H, Ivey B, et al. Assessment of the early risks of CVS. Can Med Assoc J. 1986;134:753-756.
79. Pergament E, Schulman J, Copeland K, et al. The risk of and efficiency of chorionic villus sampling in multiple gestations. Prenat Diagn. 1992;12:377-384.
80. Brambati B, Tukui L, Lanzani A, et al. First-trimester genetic diagnosis in multiple pregnancy: Principles and pitfalls. Prenat Diagn. 1991;11:767-774.
81. Wapner RJ, Barr MA, Heeger S, et al. Chorionic villus sampling: A 10-year, over 13,000 consecutive case experience. American College of Medical Genetics, First Annual Meeting, Orlando, FL, March 1994.
82. Jenkins TM, Wapner RJ. The challenge of prenatal diagnosis in twin pregnancies. Curr Opin Obstet Gynecol. 2000;12:87-62.
83. Wapner RJ, Johnson A, Davis G. Prenatal diagnosis in twin gestations: A comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling. Obstet Gynecol. 1993;82:49-56.
84. Valenti C. Antenatal detection of hemoglobinopathies. A preliminary report. Am J Obstet Gynecol. 1973;115:851-853.
85. Hobbins JC, Mahoney MJ, Goldstein LA. New method of intrauterine evaluation by the combined use of fetoscopy and ultrasound. Am J Obstet Gynecol. 1974;118:1069-1072.
86. Hobbins JC, Mahoney MF. In utero diagnosis of hemoglobinopathies. Technic for obtaining blood. N Engl J Med. 1974;290:1065-1067.
87. Berkowitz RL, Chitkara U, Goldberg JD, et al. Intravascular transfusion in utero: The percutaneous approach. Am J Obstet Gynecol. 1986;154:622-623.
88. Daffos F, Capella-Pavlovsky M, Forestier F. A new procedure for fetal blood sampling in utero: Preliminary results in fifty-three cases. Am J Obstet Gynecol. 1983;146:985-987.
89. Weiner CP. Cordocentesis for diagnostic indications: Two years' experience. Obstet Gynecol. 1987;70:664-668.
90. Nicolini U, Nicolaidis P, Fisk NM, et al. Fetal blood sampling from the intrahepatic vein: Analysis of safety and clinical experience with 214 procedures. Obstet Gynecol. 1990;76:47-53.
91. Antsaklis AI, Papantoniou NE, Mesogitis SA, et al. Cardiocentesis: An alternative method of fetal blood sampling for the prenatal diagnosis of hemoglobinopathies. Obstet Gynecol. 1992;79:630-633.
92. Ghidini A, Sepulveda W, Lockwood CJ, et al. Complications of fetal blood sampling. Am J Obstet Gynecol. 1993;168:1339-1344.
93. Weiner CP, Okamura K. Diagnostic fetal blood sampling-technique related losses. Fetal Diagn Ther. 1996;11:169-175.
94. Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: A study of 606 consecutive cases. Am J Obstet Gynecol. 1985;153:655-660.
95. Weiner CP, Wenstrom KD, Sipes SL, et al. Risk factors for cordocentesis and fetal intravascular transfusion. Am J Obstet Gynecol. 1991;165:1020-1025.